Chemours earnings on deck as company faces PFAS settlement costs
Aug 4, 2026
Chemours anticipates improved Q2 earnings with $1.66 billion revenue, while investors monitor the impact of its $450 million PFAS settlement and titanium dioxide trends. Despite a Buy rating, analysts express tempered optimism regarding margin sustainability ahead of the report.
Show all 98 updates